17.1 High-Alert Medications & Error-Prone Abbreviations
Key Takeaways
- High-alert medicines cause disproportionately severe harm when an error occurs — ISMP's list includes insulin, anticoagulants, opioids, concentrated electrolytes, weekly methotrexate, digoxin, neuromuscular blockers, and chemotherapy
- Mitigation centres on independent double-checks, standardised concentrations, tall-man lettering, smart pumps with DERS, and segregation of concentrated electrolytes from floor stock
- The abbreviation "U" for units has been misread as "0", causing 10-fold insulin overdoses; write "units" in full
- Never use a trailing zero (1.0 mg) or omit a leading zero (.5 mg) — both produce 10-fold dosing errors
- Weekly oral methotrexate must be labelled "WEEKLY"; daily dosing causes fatal pancytopenia and mucositis
High-Alert Medications
High-alert medications (also called high-risk medicines) are drugs that carry a significantly elevated risk of causing serious patient harm when used in error. The Institute for Safe Medication Practices (ISMP) maintains the canonical list that the DHA blueprint draws from. A common exam trap is to assume "high-alert" means the drug is more error-prone — it does not. It means that when an error occurs, the consequences are more severe.
ISMP High-Alert Categories Every Pharmacist Must Know
| Category | Examples | Typical Harm |
|---|---|---|
| Insulin (all formulations) | Regular, glargine, U-100, U-500 | Severe hypoglycaemia, brain damage, death |
| Anticoagulants | Heparin (IV/SC), warfarin, apixaban, rivaroxaban, dabigatran, enoxaparin | Major bleeding |
| Opioids | Morphine, hydromorphone, fentanyl, methadone, oxycodone | Respiratory depression, fatal overdose |
| Concentrated electrolytes | Potassium chloride concentrate, hypertonic saline ≥3%, magnesium sulfate | Cardiac arrest, hyperkalaemia |
| Methotrexate (oral, weekly) | Rheumatoid arthritis / psoriasis doses | Pancytopenia if given daily |
| Digoxin | Tablets, elixir | Arrhythmia, toxicity |
| Neuromuscular blockers | Rocuronium, suxamethonium, vecuronium | Respiratory paralysis if not ventilated |
| Chemotherapy | Vincristine, IV methotrexate, doxorubicin | Cytotoxic catastrophe |
| Oral hypoglycaemics | Sulfonylureas (glibenclamide, glimepiride) | Severe, prolonged hypoglycaemia |
Risk-Reduction Strategies
The pharmacist's role is to engineer safety into the system so that a single human slip does not reach the patient:
- Independent double-check: two qualified clinicians separately verify drug, dose, route, rate, and patient identity before administering high-alert IV medicines. The check is independent — neither clinician tells the other what they expect to see.
- Standardised concentrations: heparin 25,000 units/250 mL, morphine 1 mg/mL, insulin infusion 1 unit/mL. Standardisation removes calculation steps.
- Tall-man lettering: capitalise distinctive parts of look-alike names — predniSONE vs prednisoLONE, DOBUTamine vs DOPamine, hyDROmorphone vs morphine, NIFEdipine vs niCARdipine.
- Smart pumps with dose error-reduction software (DERS): hard upper limits on opioid, heparin, and insulin infusion rates; the pump refuses to deliver above the soft or hard cap.
- Segregation and limited access: concentrated potassium chloride and hypertonic saline ≥3% must be stored outside patient-care areas, never as floor stock; heparin flushes separated from heparin infusions.
Exam Trap — Methotrexate Weekly, Not Daily
A classic DHA-style stem exploits the weekly oral methotrexate regimen used for rheumatoid arthritis and psoriasis. Prescribing or dispensing it as "daily" causes fatal pancytopenia, mucositis, and sepsis. Always verify the frequency is once weekly (sometimes split into three divided doses 12 hours apart on the same day of the week) and label the box "WEEKLY" with a prominent warning. Oncology methotrexate, by contrast, may be high-dose IV on a multi-day cycle — the route and indication change the risk profile.
Error-Prone Abbreviations (ISMP Do-Not-Use List)
The ISMP List of Error-Prone Abbreviations, Symbols, and Dose Designations catalogues notations linked to harmful medication errors. The DHA exam tests the most dangerous entries.
| Prohibited | Why It's Dangerous | Write Instead |
|---|---|---|
| U or u (for units) | Misread as "0" — insulin 10U read as 100 units, 10-fold overdose | units |
| IU (international unit) | Misread as "IV" (intravenous) or "1" | international unit |
| QD, Q.D., q.d. | Mistaken for QID (four times daily) | daily |
| QOD, q.o.d. | Mistaken for QD or QID | every other day |
| Trailing zero (1.0 mg) | Decimal missed — given as 10 mg | 1 mg |
| Missing leading zero (.5 mg) | Decimal missed — given as 5 mg | 0.5 mg |
| MS, MSO4, MgSO4 | Confusion between morphine sulfate and magnesium sulfate | morphine, magnesium sulfate |
| cc (cubic centimetre) | Misread as "U" (units) | mL |
| μg (microgram) | Misread as mg — 1000-fold overdose | mcg or microgram |
| @, &, >, < | Ambiguous in handwriting | "at", "and", "greater than", "less than" |
| AS, AD, AU (ear) | Confused with OS/OD (eye) — wrong site | "left ear", "right ear", "both ears" |
The 10-Fold Error Pattern
Almost every exam question on this topic tests the 10-fold dosing error. Three mechanisms produce it:
- "U" → "0": 6U regular insulin read as 60 units.
- Missing leading zero: .5 mg digoxin read as 5 mg (10× the dose).
- Trailing zero: 1.0 mg warfarin read as 10 mg.
These are sentinel events. The corrective rule is always the same: write the unit word in full, never append a trailing zero, and never omit a leading zero.
Tall-Man Lettering Pairs to Memorise
- DOBUTamine vs DOPamine — very different haemodynamic profiles
- hyDROmorphone vs morphine — hydromorphone is roughly 5–7× more potent
- predniSONE vs prednisoLONE — different potencies and indications
- cycloSERINE vs cycloSPORINE — anti-tubercular vs immunosuppressant
- chlorPROmazine vs chloramphenicol — antipsychotic vs antibiotic
- NIFEdipine vs niCARdipine — different onset and clinical use
When a question shows a handwritten or transcribed order with any of the abbreviations above, the safest pharmacist action is almost always to contact the prescriber to clarify — never guess, never "interpret" a prohibited abbreviation.
A nurse asks the pharmacy why a heparin order reading "heparin 25,000 U in 250 mL D5W" was held. Which is the BEST explanation for the pharmacist's intervention?
Which of the following orders is written in a form that is safe to dispense without clarification?
Tall-man lettering "hyDROmorphone" is used primarily to distinguish it from which other drug on order entry screens?
A prescriber writes "MSO4 2 mg IV" for a post-operative patient. What is the safest pharmacist action?